| 1. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.. Proc Natl Acad Sci USA, 97 (7): (3207-12). [PMID:10716737] [10.1021/op500134e] |
| 2. Deng JT, Van Lierop JE, Sutherland C, Walsh MP. (2001) Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase.. J Biol Chem, 276 (19): (16365-73). [PMID:11278951] [10.1021/op500134e] |
| 3. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. (2001) Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343.. J Biol Chem, 276 (29): (27462-9). [PMID:11313365] [10.1021/op500134e] |
| 4. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH. (2001) Integrin-linked kinase expression increases with prostate tumor grade.. Clin Cancer Res, 7 (7): (1987-91). [PMID:11448915] [10.1021/op500134e] |
| 5. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. (2002) Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase.. Biochem J, 367 (Pt 2): (517-24). [PMID:12144526] [10.1021/op500134e] |
| 6. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W. (2003) Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.. Virchows Arch, 442 (2): (118-23). [PMID:12596061] [10.1021/op500134e] |
| 7. Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S. (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.. J Biol Chem, 278 (25): (22374-8). [PMID:12686550] [10.1021/op500134e] |
| 8. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. (2003) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.. J Pathol, 201 (2): (229-37). [PMID:14517840] [10.1021/op500134e] |
| 9. Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J. (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.. J Pathol, 208 (1): (91-9). [PMID:16278819] [10.1021/op500134e] |
| 10. Schaeffer DF, Assi K, Chan K, Buczkowski AK, Chung SW, Scudamore CH, Weiss A, Salh B, Owen DA. (2010) Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.. Virchows Arch, 456 (3): (261-8). [PMID:20091050] [10.1021/op500134e] |
| 11. Pontier SM, Huck L, White DE, Rayment J, Sanguin-Gendreau V, Hennessy B, Zuo D, St-Arnaud R, Mills GB, Dedhar S et al.. (2010) Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.. Oncogene, 29 (23): (3374-85). [PMID:20305688] [10.1021/op500134e] |
| 12. Chan J, Ko FC, Yeung YS, Ng IO, Yam JW. (2011) Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma.. PLoS ONE, 6 (2): (e16984). [PMID:21347395] [10.1021/op500134e] |
| 13. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS. (2011) Identification and characterization of a novel integrin-linked kinase inhibitor.. J Med Chem, 54 (18): (6364-74). [PMID:21823616] [10.1021/op500134e] |
| 14. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.. Proc Natl Acad Sci USA, 95 (19): (11211-6). [PMID:9736715] [10.1021/op500134e] |
B2402420